{"nct_id":"NCT02132130","title":"Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2014-06-23","start_date_type":"ACTUAL","primary_completion_date":"2019-12-09","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}